Simultaneous Determination of Losartan and Rosuvastatin in Rat Plasma Using Liquid Chromatography–Tandem Mass Spectrometric Technique for Application into Pharmacokinetic and Drug–Drug Interaction Studies-Reference-Cited by-同舟云学术

Simultaneous Determination of Losartan and Rosuvastatin in Rat Plasma Using Liquid Chromatography–Tandem Mass Spectrometric Technique for Application into Pharmacokinetic and Drug–Drug Interaction Studies

Published:2020-09-28 Issue:12 Volume:83 Page:1477-1494
ISSN:0009-5893
Container-title:Chromatographia
language:en
Short-container-title:Chromatographia

Author:

Wadie Magdy Atef^ORCID,Kishk Safaa M.,Darwish Khaled M.,Mostafa Samia M.,Elgawish Mohamed Saleh

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10337-020-03967-z.pdf

Reference36 articles.

1. Horiuchi M, Cui TX, Li Z, Li JM, Nakagami H, Iwai M (2003) Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation. Circulation 107(1):106–112. https://doi.org/10.1161/01.cir.0000043244.13596.20

2. Moon MC, Molnar K, Yau L, Zahradka P (2004) Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury. J Vasc Surg 40(1):130–137. https://doi.org/10.1016/j.jvs.2004.02.031

3. Preusch MR, Vanakaris A, Bea F, Ieronimakis N, Shimizu T, Konstandin M, Morris-Rosenfeld S, Albrecht C, Kranzhöfer A, Katus HA, Blessing E, Kranzhöfer R (2010) Rosuvastatin reduces neointima formation in a rat model of balloon injury. Eur J Med Res 15(11):461–467. https://doi.org/10.1186/2047-783x-15-11-461

4. Lee SG, Lee SJ, Thuy NVP, Kim JS, Lee JJ, Lee OH, Kim CK, Oh J, Park S, Kim SH, Lee SH, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y (2019) Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis. PLoS ONE 14(5):e0215604. https://doi.org/10.1371/journal.pone.0215604

5. Yi I, Lee J-J, Park J-S, Zhang WY, Kim I-S, Kim Y, Shin C-Y, Kim HS, Myung C-S (2010) Enhanced effect of losartan and rosuvastatin on neointima hyperplasia. Arch Pharmacal Res 33(4):593–600

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing losartan potassium-laden pegylated nanocubic vesicles as a novel nanoplatform to alleviate cisplatin-induced nephrotoxicity via blocking apoptosis and activating the wnt/β-catenin/TCF-4 pathway;Life Sciences;2024-10

2. Nanocomposite alginate hydrogel loaded with propranolol hydrochloride kolliphor® based cerosomes as a repurposed platform for Methicillin-Resistant Staphylococcus aureus-(MRSA)-induced skin infection; in-vitro, ex-vivo, in-silico, and in-vivo evaluation;Drug Delivery and Translational Research;2024-05-18

3. Assembly of In-Situ Gel Containing Nano-Spanlastics of an Angiotensin II Inhibitor as a Novel Epitome for Hypertension Management: Factorial Design Optimization, In-vitro Gauging, Pharmacokinetics, and Pharmacodynamics Appraisal;AAPS PharmSciTech;2024-05-16

4. Development of a highly sensitive and eco-friendly high-performance thin-layer chromatography approach for the determination of empagliflozin, pioglitazone, and rosuvastatin simultaneously in pharmaceutical preparations and different biological fluids;JPC – Journal of Planar Chromatography – Modern TLC;2023-12-21

5. Development and Validation of an Analytical RP-HPLC Method for Simultaneous Estimation of Losartan and its Active Metabolite (EXP-3174) in Isolated Perfused Rat Liver;Current Pharmaceutical Analysis;2023-12